Janux Therapeutics (JANX) Capital Expenditures (2021 - 2026)
Janux Therapeutics (JANX) reported Capital Expenditures of $202,000 for Q2 2026, down 57.3% from $473,000 a year earlier and down 26.0% from the prior quarter.
Powered by 
Analysis
Janux Therapeutics (JANX) Capital Expenditures (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Janux Therapeutics' Capital Expenditures came in at $674,000, down 26.0% year-over-year; for FY2025, it came in at $1.04 million, up 190.5% from FY2024.
- Capital Expenditures has a four-year compound annual growth rate of -8.4% (FY2021 to FY2025).
- By year, Capital Expenditures came in at $359,000 in FY2024 (-80.6%), $1.85 million in FY2023 (-71.3%), $6.45 million in FY2022 (+334.9%) and $1.48 million in FY2021.
- Five-year quarterly Capital Expenditures spans a low of $25,000 in Q3 2024 and a high of $2.52 million in Q3 2022.
- Year over year, Capital Expenditures gained in four of the last eight quarters, with growth averaging 80.0%.
- The high point for year-over-year Capital Expenditures in five years was Q1 2022 (growth of 534.6%); the low point was Q3 2024 (a decline of 94.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $273,000 (Q1 2026), $106,000 (Q4 2025) and $93,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Janux Therapeutics | 1.06 Bn | -2.82 Bn | - | 202,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 202,000.00 |
| Mar 31, 2026 | 273,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 473,000.00 |
| Mar 31, 2025 | 371,000.00 |
| Dec 31, 2024 | 42,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 95,000.00 |
| Mar 31, 2024 | 197,000.00 |
| Dec 31, 2023 | 515,000.00 |
| Sep 30, 2023 | 470,000.00 |
| Jun 30, 2023 | 580,000.00 |
| Mar 31, 2023 | 285,000.00 |
| Dec 31, 2022 | 2.06 Mn |
| Sep 30, 2022 | 2.52 Mn |
| Jun 30, 2022 | 898,000.00 |
| Mar 31, 2022 | 971,000.00 |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 77,000.00 |
API Access
Janux Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=JANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "JANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=JANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();